Hillevax Inc
Biotechnology
Healthcare
HLVX
49.98 M shares
NASDAQ US
traded
16 Sep 2025
listed
no
open
2.10
52 week high
2.17
high
2.11
52 week low
0.00
low
2.09
growth
16.11 %
previous Close
2.10
P/E ratio
market cap
103 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-5.27 M
13.12 %
eps
0.00 %
-91.67 %
eps surprise
20.69 %
net profit margin
-526600000.00 %
0.00 %
operating incoming
-6.99 M
8.14 %
net change in cash
11.19 M
110.46 %
cash on hand
58.68 M
23.57 %
cost of revenue
0.00 %
top top